Altria Introduces SWIC: Innovative Tobacco Heating Device in UK

Dec.16.2024

Altria introduces new SWIC tobacco device in UK, offering online sales of innovative heating technology for KETLEpod.

According to Tobacco Insider on December 13th, Altria has begun test market sales of its new heated tobacco device SWIC in the UK. The sales are being conducted through online channels.

According to the company, the SWIC device is used in conjunction with KETLEpods and can be used 14 times per charge. The device is equipped with vibration feedback functionality and a screen to display battery level and remaining pod quantity. The SWIC starter kit is priced at £14.49 and includes one device and three boxes of corresponding pod products (each box contains 15 pods in gold, red, and green). Purchasing a single box separately costs £3.49, while 20 boxes are priced at £59.80. Each pod is for disposable use.

KETLEpod offers three flavors: Gold, Red, and Green. KETLE Gold provides a balanced tobacco flavor with each pod containing 0.5mg of nicotine. KETLE Red offers a rich tobacco flavor with each pod containing 0.7mg of nicotine. KETLE Green is a blend of tobacco and mint flavors, with each pod also containing 0.7mg of nicotine.

The SWIC device is manufactured by HelixSweden, a subsidiary of Altria, using HeatGrid heating technology. Altria first announced the development of the SWIC device in the spring of 2023, claiming it to be the first heated tobacco device to use filled tobacco pods.

Altria claims that consumers find the concept of SWIC products innovative and unique, and believe that the device is simpler and more user-friendly compared to other heated tobacco products like IQOS.

References:

[1] SWIC Heated Tobacco Device

Also Read:

[1] Altria's Report Exposes Widespread Nicotine Mislabeling in Illegal E-Cigarettes

[2] Altria Q3 revenue slips 0.4% to $6.3 billion as NJOY gains market share

[3] Altria Group's Q2 Performance: On! Nicotine Pouches Achieve Best Sales in a Year

[4] Altria's Q2 and H1 Results: Net Revenue Falls 4.6% to $6.209 Billion in Q2 Amid Notable Market Share Growth for NJOY

[5] Altria Submits Data on Illicit Nicotine Pouches to FDA, Drawing Parallels to Early E-Cigarette Black Market

[6] Altria Group Submits PMTA for on! PLUS Nicotine Pouches

#Europe #United Kingdom #Products #Heated tobacco products

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement

President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.

Nov.14 by 2FIRSTS.ai

Russia’s Federation Council Approves Ban on Vape and Cigarette Sales at Transport Stops

Russia’s Federation Council has approved a law banning the sale of all nicotine-containing products, including cigarettes and e-cigarettes, at urban and suburban public transport stops. The law includes an exemption for cases where a retail outlet at a stop is the only point of sale in a locality. The legislation will come into force on September 1, 2026.

Dec.19 by 2FIRSTS.ai

Switzerland's Geneva to enforce ban on disposable e-cigarettes following court ruling

The Canton of Geneva has begun enforcing its ban on disposable e-cigarettes (“puffs”) after the cantonal court rejected industry appeals to suspend the law. Passed on August 29 by the Grand Council, the ban will now be actively monitored by trade inspectors, while a similar measure is already in force in Valais.

Nov.07 by 2FIRSTS.ai

Illegal Vape Suppliers Move Online After Queensland Crackdown

Less than two weeks after Queensland police raided and shut down tobacconists suspected of selling illegal e-cigarettes, at least one supplier has moved its business online. Flyers with QR codes advertising same-day delivery of vapes, tobacco, and nicotine pouches were found taped to electricity poles across the Gold Coast.